The facility expansion is planned to ensure a global supply of functional excipients for RNA therapeutics while also boosting the biopharmaceutical excipient sector. Biopharmaceutical Excipient Manufacturing Market Dynamics:Market Drivers: Rise in Biologics DevelopmentAs the cancer burden grows, so does the demand for a wide range of biological therapies. The biopharmaceutical excipient manufacturing market in North America is expected to have substantial revenue growth and a strong CAGR in the near future. The region's growth can be attributed to the existence of multiple prominent pharmaceutical manufacturing enterprises. This has prompted some regional excipient manufacturers to attain the necessary production scalability by utilizing biopharmaceutical excipients that meet regulatory standards.
